WEST VIRGINIA UNIVERSITY
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1867-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.wvu.edu
Clinical Trials
140
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (130 trials with phase data)• Click on a phase to view related trials
Preventing Perinatal Anxiety: Testing an Internet-delivered Intervention
- Conditions
- Postpartum Disorder
- First Posted Date
- 2025-07-17
- Last Posted Date
- 2025-07-17
- Lead Sponsor
- West Virginia University
- Target Recruit Count
- 100
- Registration Number
- NCT07071025
- Locations
- 🇺🇸
Life Sciences Building, Morgantown, West Virginia, United States
Remote Vinyasa Yoga Program for Heart Health
- Conditions
- HypertensionCardiovascular Diseases
- First Posted Date
- 2025-05-08
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- West Virginia University
- Target Recruit Count
- 30
- Registration Number
- NCT06961981
- Locations
- 🇺🇸
West Virginia University, Morgantown, West Virginia, United States
Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management
- Conditions
- Breast CancerFatigue
- First Posted Date
- 2025-05-07
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- West Virginia University
- Target Recruit Count
- 60
- Registration Number
- NCT06960720
- Locations
- 🇺🇸
West Virginia University, Morgantown, West Virginia, United States
Rate of Allergic Contact Dermatitis and Cosmetic Outcomes
- Conditions
- Allergic Contact DermatitisOsteoarthritis, HipOsteoarthritis, Knee
- First Posted Date
- 2025-05-04
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- West Virginia University
- Target Recruit Count
- 600
- Registration Number
- NCT06957444
- Locations
- 🇺🇸
West Virginia University, Morgantown, West Virginia, United States
Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes
- Conditions
- Myelodysplastic Syndromes
- Interventions
- First Posted Date
- 2025-04-11
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- West Virginia University
- Target Recruit Count
- 26
- Registration Number
- NCT06923488
- Locations
- 🇺🇸
West Virginia University Cancer Institute, Morgantown, West Virginia, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 28
- Next
News
FDA Clears ZEISS INTRABEAM 700: Advanced Robotic-Assisted Platform for Intraoperative Radiotherapy
ZEISS INTRABEAM 700 has received FDA 510(k) clearance, offering robotic-assisted precision for intraoperative radiation therapy in neuro-oncology and breast cancer treatment.
WVU Study to Compare Buprenorphine Formulations for Opioid Use Disorder in Rural Setting
West Virginia University (WVU) will conduct a study comparing oral film versus injectable buprenorphine for opioid use disorder treatment in rural areas.
NIH Launches CARE for Health Network to Enhance Primary Care Research
The NIH is investing $30 million to launch the CARE for Health network, aimed at integrating clinical research with community-based primary care.